(19)
(11) EP 1 879 877 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
13.02.2013 Bulletin 2013/07

(45) Mention of the grant of the patent:
02.01.2013 Bulletin 2013/01

(21) Application number: 06744865.4

(22) Date of filing: 03.05.2006
(51) International Patent Classification (IPC): 
C07D 333/34(2006.01)
 A61K 31/381(2006.01)
(86) International application number:
PCT/IB2006/051397
(87) International publication number:
WO 2006/117762 (09.11.2006 Gazette 2006/45)

(54)

ANTIMICROBIAL AGENTS

ANTIMIKROBIELLE MITTEL

AGENTS ANTIMICROBIENS

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 03.05.2005 IN DE11022005
22.07.2005 IN DE19362005
10.04.2006 IN DE09782006

(43) Date of publication of application:
23.01.2008 Bulletin 2008/04

(73) Proprietor: Ranbaxy Laboratories Limited
New Delhi 110019 Delhi (IN)

(72) Inventors:
  • DAS, Biswajit
    Gurgaon, Haryana 122001 (IN)
  • ARORA, Jasbir, Singh
    Gurgaon, Haryana 122002 (IN)
  • AHMED, Shahadat
    Sohna Rd, Gurgaon, Haryana122101 (IN)
  • BANDYOPADHYAY, Anish
    Gurgaon, Haryana 122002 (IN)
  • KATOCH, Rita
    Chandigarh 160055 (IN)
  • KURHADE, Santosh, Haribhau
    Gurgaon, Haryana 122001 (IN)
  • RATHY, Sujata
    Delhi 110034 (IN)
  • GHOSH, Soma
    Punjab 160059 (IN)
  • KHOJE, Abhijit, Datta
    Gurgaon, Haryana 122001 (IN)
  • GUJRATI, Arti
    Gurgaon, Haryana 122002 (IN)
  • UPADHYAY, Dilip, J.
    Kalyan (w), Maharashtra 421301 (IN)

(74) Representative: Cronin, Brian Harold John 
CRONIN Intellectual Property Chemin de Précossy 31
1260 Nyon
1260 Nyon (CH)


(56) References cited: : 
WO-A-01/26654
FR-A1- 2 518 544
US-A- 5 059 602
 WO-A-2004/056816
JP-A- 57 085 346
US-A1- 2003 013 724
   
  • HUMBER L G: "AGENTS AFFECTING LIPID METABOLISM. XII. N,N'-DISUBSTITUTED CYCLOHEXANE-1,4-BIS(METHYLAMINES)." November 1964 (1964-11), JOURNAL OF MEDICINAL CHEMISTRY. NOV 1964, VOL. 44, PAGE(S) 826 - 830 , XP002404170 ISSN: 0022-2623 Table 1, compound 32
  • MAYER PATRICE ET AL: "New substituted 1-(2,3-dihydrobenzo(1,4)dioxin-2-ylmethyl) piperidin- 4-yl derivatives with alpha2-adrenoceptor antagonist activity" 5 October 2000 (2000-10-05), JOURNAL OF MEDICINAL CHEMISTRY, VOL. 43, NR. 20, PAGE(S) 3653-3664 , XP002404171 ISSN: 0022-2623 page 3656, scheme 3, compound 39
  • BAR-HAIM G ET AL: "Regioselective N-alkylation of 2-aminobenzylamine via chelation to 9- BBN" 23 April 1998 (1998-04-23), TETRAHEDRON LETTERS 23 APR 1998 UNITED KINGDOM, VOL. 39, NR. 17, PAGE(S) 2643-2644 , XP002404172 ISSN: 0040-4039 page 2643; compound 3D
  • PHILILIPS O A ET AL: "Synthesis and antibacterial activity of 5-substituted oxazolidinones" BIOORGANIC & MEDICINAL CHEMISTRY, ELSEVIER SCIENCE LTD, GB, vol. 11, no. 1, 2 January 2003 (2003-01-02), pages 35-41, XP002283683 ISSN: 0968-0896
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).